Latest Financials News

CGN Resources has completed a significant drilling campaign at its Webb Project, uncovering new geological insights, while also expanding its tenement holdings in Western Australia's Leonora gold district and the Paterson Province's Broadhurst Project.

Imugene Limited has launched a $37.5 million equity raising through a Placement and Share Purchase Plan, offering new shares and options to fund its pivotal azer-cel clinical program. The raise includes attaching and piggyback options, subject to shareholder approval, aiming to bolster the company’s immuno-oncology pipeline.

Imugene Limited has completed a $22.5 million institutional placement and launched a $15 million Share Purchase Plan, both featuring attaching options, to fund its azer-cel clinical program through a pivotal trial in 2026.

Lumos Diagnostics Holdings Limited has had its ASX trading suspension lifted following news of a strategic material agreement, signaling potential growth ahead.

Lumos Diagnostics has inked a landmark six-year exclusive distribution agreement with PHASE Scientific for its FebriDx® rapid diagnostic test in the US, potentially unlocking nearly half a billion Australian dollars in revenue contingent on FDA approval.

Caspin Resources has completed the second tranche of its $2.1 million capital raising, issuing shares and free-attaching options approved by shareholders. The move strengthens funding for its diverse Australian mineral projects.

Hawsons Iron Limited has successfully raised $1.91 million through an oversubscribed Share Purchase Plan and a targeted Placement, positioning the company to fast-track key project studies and environmental assessments.

Warriedar Resources has announced a landmark mineral resource upgrade at its Ricciardo deposit, now home to Australia’s largest open-pit antimony resource, alongside significant gold discoveries and a successful A$21 million capital raise to accelerate exploration.

Future Generation Global has reported a strong 20.8% investment portfolio return for the year ending June 2025, prompting an increase in its fully franked interim dividend to 4.0 cents per share. This marks the sixth consecutive year of dividend growth for the ASX-listed investment company.

ImpediMed has doubled its US unit sales in Q4 FY25, achieving a record total contract value and securing an additional $5 million tranche under its growth capital facility.

DigitalX Limited reports a $75.6 million treasury valuation driven by Bitcoin and digital assets, completing a $20.7 million capital raise to expand its Bitcoin-first strategy.

Close the Loop Limited announces a strategic leadership overhaul with new CEOs appointed for North America and Australia, alongside a streamlined operational focus on three core business units.